Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head

Osteonecrosis of the femoral head (ONFH) is a prevalent orthopedic disorder characterized primarily by compromised blood supply. This vascular deficit results in cell apoptosis, trabecular bone loss, and structural collapse of the femoral head at late stage, significantly impairing joint function. W...

Full description

Saved in:
Bibliographic Details
Main Authors: Weihong Zhu, Zhenmu Xu, Ding Zhou, Jiankun Xu, Yuchen He, Zhong Alan Li
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Journal of Tissue Engineering
Online Access:https://doi.org/10.1177/20417314241310541
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586586901970944
author Weihong Zhu
Zhenmu Xu
Ding Zhou
Jiankun Xu
Yuchen He
Zhong Alan Li
author_facet Weihong Zhu
Zhenmu Xu
Ding Zhou
Jiankun Xu
Yuchen He
Zhong Alan Li
author_sort Weihong Zhu
collection DOAJ
description Osteonecrosis of the femoral head (ONFH) is a prevalent orthopedic disorder characterized primarily by compromised blood supply. This vascular deficit results in cell apoptosis, trabecular bone loss, and structural collapse of the femoral head at late stage, significantly impairing joint function. While MRI is a highly effective tool for diagnosing ONFH in its early stages, challenges remain due to the limited availability and high cost of MRI, as well as the absence of routine MRI screening in asymptomatic patients. . In addition, current therapeutic strategies predominantly only relieve symptoms while disease-modifying ONFH drugs are still under investigation/development. Considering that blood supply of the femoral head plays a key role in the pathology of ONFH, angiogenic therapies have been put forward as promising treatment options. Emerging bioengineering interventions targeting angiogenesis hold promising potential for ONFH treatment. In this review, we introduce the advances in research into the pathology of ONFH and summarize novel bioengineering interventions targeting angiogenesis. This review sheds light upon new directions for future research into ONFH.
format Article
id doaj-art-8f419f1590924803a8ec925a9c205658
institution Kabale University
issn 2041-7314
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Journal of Tissue Engineering
spelling doaj-art-8f419f1590924803a8ec925a9c2056582025-01-25T07:03:37ZengSAGE PublishingJournal of Tissue Engineering2041-73142025-01-011610.1177/20417314241310541Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral headWeihong Zhu0Zhenmu Xu1Ding Zhou2Jiankun Xu3Yuchen He4Zhong Alan Li5Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaInnovative Orthopaedic Biomaterial and Drug Translational Research Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, ChinaDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, ChinaShenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, ChinaOsteonecrosis of the femoral head (ONFH) is a prevalent orthopedic disorder characterized primarily by compromised blood supply. This vascular deficit results in cell apoptosis, trabecular bone loss, and structural collapse of the femoral head at late stage, significantly impairing joint function. While MRI is a highly effective tool for diagnosing ONFH in its early stages, challenges remain due to the limited availability and high cost of MRI, as well as the absence of routine MRI screening in asymptomatic patients. . In addition, current therapeutic strategies predominantly only relieve symptoms while disease-modifying ONFH drugs are still under investigation/development. Considering that blood supply of the femoral head plays a key role in the pathology of ONFH, angiogenic therapies have been put forward as promising treatment options. Emerging bioengineering interventions targeting angiogenesis hold promising potential for ONFH treatment. In this review, we introduce the advances in research into the pathology of ONFH and summarize novel bioengineering interventions targeting angiogenesis. This review sheds light upon new directions for future research into ONFH.https://doi.org/10.1177/20417314241310541
spellingShingle Weihong Zhu
Zhenmu Xu
Ding Zhou
Jiankun Xu
Yuchen He
Zhong Alan Li
Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head
Journal of Tissue Engineering
title Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head
title_full Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head
title_fullStr Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head
title_full_unstemmed Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head
title_short Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head
title_sort bioengineering strategies targeting angiogenesis innovative solutions for osteonecrosis of the femoral head
url https://doi.org/10.1177/20417314241310541
work_keys_str_mv AT weihongzhu bioengineeringstrategiestargetingangiogenesisinnovativesolutionsforosteonecrosisofthefemoralhead
AT zhenmuxu bioengineeringstrategiestargetingangiogenesisinnovativesolutionsforosteonecrosisofthefemoralhead
AT dingzhou bioengineeringstrategiestargetingangiogenesisinnovativesolutionsforosteonecrosisofthefemoralhead
AT jiankunxu bioengineeringstrategiestargetingangiogenesisinnovativesolutionsforosteonecrosisofthefemoralhead
AT yuchenhe bioengineeringstrategiestargetingangiogenesisinnovativesolutionsforosteonecrosisofthefemoralhead
AT zhongalanli bioengineeringstrategiestargetingangiogenesisinnovativesolutionsforosteonecrosisofthefemoralhead